NCT00864357View on ClinicalTrials.gov

A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

Oxycodone HCl 5 mg / Ibuprofen 400 mg tablets, single dose

A: Experimental SSubjects received Actavis formulated products under non-fasting conditions

DRUG

COMBONOX® tablets, single dose

B: Active comparator Subjects received Forest Pharmaceuticals, Inc formulated products under non-fasting conditions

Trial Locations (1)

63301

Gateway Medical Research, Inc, Saint Charles

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY